KLINGENSTEIN PAUL H 4
4 · Clovis Oncology, Inc. · Filed Oct 15, 2018
Insider Transaction Report
Form 4
KLINGENSTEIN PAUL H
Director
Transactions
- Award
Stock Option (right to buy)
2018-10-11+14,770→ 14,770 totalExercise: $27.92Exp: 2028-10-11→ Common Stock (14,770 underlying)
Footnotes (1)
- [F1]One-twelfth (1/12) of the shares subject to the option shall vest on each of the first twelve (12) monthly anniversaries of the date of grant.